Lol, imagine us holders!
Perhaps a clue from previous announcement on sale of.
”Admedus notes that the Immunotherapies Transaction remains subject to a number of conditions, including the signing of the Subscription Agreement, which means it is not currently certain the translation will proceed”.
Either some fine tuning or something left field!
Worst case scenario shouldn’t effect sp, doubt if any value of this (being sold) is incorporated in the current sp, imo.
News: AHZ Admedus Seeks Trading Halt Pending Announcement On Admedus Immunotherapies Sale..., page-3
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$14.00 |
Change
0.800(6.06%) |
Mkt cap ! $295.9M | |||
| Open | High | Low | Value | Volume |
| $13.08 | $14.00 | $12.84 | $202.5K | 15.04K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 88 | $13.20 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $14.00 | 1109 | 2 |
View Market Depth
| Last trade - 16.10pm 29/08/2024 (20 minute delay) ? |
| AVR (ASX) Chart |